EP3515937
MEÐFERÐ Á ÓMEÐFERÐARHÆFRI MIGRÆNU
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.9.2017EP published:
17.12.2025EP application number:
17785013.8
EP translation filed:
16.2.2026Grant published:
11.3.2026EPO information:
European Patent Register
Max expiry date:
21.9.2037Expiry date:
21.9.2026
Title in English:
TREATING REFRACTORY MIGRAINELanguage of the patent:
English
Timeline
Today
22.9.2017EP application
17.12.2025EP Publication
16.2.2026Translation submitted
11.3.2026Registration published
21.9.2026Expires
Owner
Name:
Teva Pharmaceuticals International GmbHAddress:
Schlüsselstrasse 12, 8645 Rapperswil-Jona, CH
Inventor
Name:
BIGAL, MarceloAddress:
Doylestown Pennsylvania 18902, US
Name:
AYCARDI, ErnestoAddress:
Andover Massachusetts 10810, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201662399180 PDate:
23.9.2016Country:
US
Number:
201762558557 PDate:
14.9.2017Country:
US
Classification
Categories:
C07K 16/18, A61P 25/06, A61K 39/00